Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta
ABSTRACT Intrahepatic cholestasis of pregnancy (ICP) causes increased transfer of maternal bile acids to the fetus and an increased incidence of sudden fetal death. Treatment includes ursodeoxycholic acid (UDCA), but it is not clear if UDCA protects the fetus. This study explores the placental trans...
Saved in:
Published in: | The FASEB journal Vol. 33; no. 7; pp. 8211 - 8220 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Federation of American Societies for Experimental Biology
01-07-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | ABSTRACT
Intrahepatic cholestasis of pregnancy (ICP) causes increased transfer of maternal bile acids to the fetus and an increased incidence of sudden fetal death. Treatment includes ursodeoxycholic acid (UDCA), but it is not clear if UDCA protects the fetus. This study explores the placental transport of the bile acid taurocholate (TC) by the organic anion–transporting polypeptide, (OATP)4A1, its effects on the placental proteome and vascular function, and how these are modified by UDCA. Various methodological approaches including placental villous fragments and Xenopus laevis oocytes were used to investigate UDCA transport. Placental perfusions and myography investigated the effect of TC on vasculature. The effects of acute TC exposure on placental tissue were investigated using quantitative proteomics. UDCA inhibited OATP4A1 activity in placental villous fragments and oocytes. TC induced vasoconstriction in placental and rat vasculature, which was attenuated by UDCA. Quantitative proteomic analysis of villous fragments showed direct effects of TC on multiple placental pathways, including oxidative stress and autophagy. The effects of TC on the placental proteome and vasculature demonstrate how bile acids may cause fetal distress in ICP. UDCA inhibition of OATP4A1 suggests it will protect the mother and fetus against the vascular effects of TC by inhibiting its cellular uptake. UDCA may protect the fetus in ICP by inhibiting OATP4A1‐mediated bile acid transfer and TC‐induced placental vasoconstriction. Understanding the physiologic mechanisms of UDCA may allow better therapeutic interventions to be designed specifically for the fetus in the future.—Lofthouse, E. M., Torrens, C., Manousopoulou, A., Nahar, M., Cleal, J. K., O'Kelly, I. M., Sengers, B. G., Garbis, S. D., Lewis, R. M. Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta. FASEB J. 33, 8211–8220 (2019). www.fasebj.org |
---|---|
AbstractList | Intrahepatic cholestasis of pregnancy (ICP) causes increased transfer of maternal bile acids to the fetus and an increased incidence of sudden fetal death. Treatment includes ursodeoxycholic acid (UDCA), but it is not clear if UDCA protects the fetus. This study explores the placental transport of the bile acid taurocholate (TC) by the organic anion–transporting polypeptide, (OATP)4A1, its effects on the placental proteome and vascular function, and how these are modified by UDCA. Various methodological approaches including placental villous fragments and
Xenopus laevis
oocytes were used to investigate UDCA transport. Placental perfusions and myography investigated the effect of TC on vasculature. The effects of acute TC exposure on placental tissue were investigated using quantitative proteomics. UDCA inhibited OATP4A1 activity in placental villous fragments and oocytes. TC induced vasoconstriction in placental and rat vasculature, which was attenuated by UDCA. Quantitative proteomic analysis of villous fragments showed direct effects of TC on multiple placental pathways, including oxidative stress and autophagy. The effects of TC on the placental proteome and vasculature demonstrate how bile acids may cause fetal distress in ICP. UDCA inhibition of OATP4A1 suggests it will protect the mother and fetus against the vascular effects of TC by inhibiting its cellular uptake. UDCA may protect the fetus in ICP by inhibiting OATP4A1-mediated bile acid transfer and TC-induced placental vasoconstriction. Understanding the physiologic mechanisms of UDCA may allow better therapeutic interventions to be designed specifically for the fetus in the future.—Lofthouse, E. M., Torrens, C., Manousopoulou, A., Nahar, M., Cleal, J. K., O’Kelly, I. M., Sengers, B. G., Garbis, S. D., Lewis, R. M. Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta. Intrahepatic cholestasis of pregnancy (ICP) causes increased transfer of maternal bile acids to the fetus and an increased incidence of sudden fetal death. Treatment includes ursodeoxycholic acid (UDCA), but it is not clear if UDCA protects the fetus. This study explores the placental transport of the bile acid taurocholate (TC) by the organic anion-transporting polypeptide, (OATP)4A1, its effects on the placental proteome and vascular function, and how these are modified by UDCA. Various methodological approaches including placental villous fragments and oocytes were used to investigate UDCA transport. Placental perfusions and myography investigated the effect of TC on vasculature. The effects of acute TC exposure on placental tissue were investigated using quantitative proteomics. UDCA inhibited OATP4A1 activity in placental villous fragments and oocytes. TC induced vasoconstriction in placental and rat vasculature, which was attenuated by UDCA. Quantitative proteomic analysis of villous fragments showed direct effects of TC on multiple placental pathways, including oxidative stress and autophagy. The effects of TC on the placental proteome and vasculature demonstrate how bile acids may cause fetal distress in ICP. UDCA inhibition of OATP4A1 suggests it will protect the mother and fetus against the vascular effects of TC by inhibiting its cellular uptake. UDCA may protect the fetus in ICP by inhibiting OATP4A1-mediated bile acid transfer and TC-induced placental vasoconstriction. Understanding the physiologic mechanisms of UDCA may allow better therapeutic interventions to be designed specifically for the fetus in the future.-Lofthouse, E. M., Torrens, C., Manousopoulou, A., Nahar, M., Cleal, J. K., O'Kelly, I. M., Sengers, B. G., Garbis, S. D., Lewis, R. M. Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta. ABSTRACT Intrahepatic cholestasis of pregnancy (ICP) causes increased transfer of maternal bile acids to the fetus and an increased incidence of sudden fetal death. Treatment includes ursodeoxycholic acid (UDCA), but it is not clear if UDCA protects the fetus. This study explores the placental transport of the bile acid taurocholate (TC) by the organic anion–transporting polypeptide, (OATP)4A1, its effects on the placental proteome and vascular function, and how these are modified by UDCA. Various methodological approaches including placental villous fragments and Xenopus laevis oocytes were used to investigate UDCA transport. Placental perfusions and myography investigated the effect of TC on vasculature. The effects of acute TC exposure on placental tissue were investigated using quantitative proteomics. UDCA inhibited OATP4A1 activity in placental villous fragments and oocytes. TC induced vasoconstriction in placental and rat vasculature, which was attenuated by UDCA. Quantitative proteomic analysis of villous fragments showed direct effects of TC on multiple placental pathways, including oxidative stress and autophagy. The effects of TC on the placental proteome and vasculature demonstrate how bile acids may cause fetal distress in ICP. UDCA inhibition of OATP4A1 suggests it will protect the mother and fetus against the vascular effects of TC by inhibiting its cellular uptake. UDCA may protect the fetus in ICP by inhibiting OATP4A1‐mediated bile acid transfer and TC‐induced placental vasoconstriction. Understanding the physiologic mechanisms of UDCA may allow better therapeutic interventions to be designed specifically for the fetus in the future.—Lofthouse, E. M., Torrens, C., Manousopoulou, A., Nahar, M., Cleal, J. K., O'Kelly, I. M., Sengers, B. G., Garbis, S. D., Lewis, R. M. Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta. FASEB J. 33, 8211–8220 (2019). www.fasebj.org |
Author | Manousopoulou, Antigoni O'Kelly, M. Ita Nahar, Monica Lofthouse, Emma M. Garbis, Spiros D. Sengers, Bram G. Lewis, Rohan M. Torrens, Christopher Cleal, Jane K. |
Author_xml | – sequence: 1 givenname: Emma M. surname: Lofthouse fullname: Lofthouse, Emma M. email: e.m.lofthouse@soton.ac.uk organization: University of Southampton – sequence: 2 givenname: Christopher surname: Torrens fullname: Torrens, Christopher organization: University of Southampton – sequence: 3 givenname: Antigoni surname: Manousopoulou fullname: Manousopoulou, Antigoni organization: University of Southampton – sequence: 4 givenname: Monica surname: Nahar fullname: Nahar, Monica organization: University of Southampton – sequence: 5 givenname: Jane K. surname: Cleal fullname: Cleal, Jane K. organization: University of Southampton – sequence: 6 givenname: M. Ita surname: O'Kelly fullname: O'Kelly, M. Ita organization: University of Southampton – sequence: 7 givenname: Bram G. surname: Sengers fullname: Sengers, Bram G. organization: University of Southampton – sequence: 8 givenname: Spiros D. surname: Garbis fullname: Garbis, Spiros D. organization: California Institute of Technology – sequence: 9 givenname: Rohan M. surname: Lewis fullname: Lewis, Rohan M. organization: University of Southampton |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30922127$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUtvEzEUhS1URNPCliXyks0EP2bsmQVIUJE-VKlSoGvLj2viMLGDPVPIv2eilCqsuvLifuc7ls4ZOokpAkJvKZlT0okPfj1nhHaEENosly_QjDacVKIV5ATNSNuxSgjenqKzUtZ7iFDxCp1y0jFGmZwhc59LcpD-7Owq9cFibYPDIa6CCUPB43bQPwHr6PCDLsmmWIYc7JAyBu_BTkjyeNBjTvu8HmDK4tW40RFve20hDvo1eul1X-DN43uO7hdfv19cVbd3l9cXn28rW9f1sgJKnDS0bbgEQ7znznGpDeuIBMadYZZoaxrTWOcZeEqF0VIw5mtqpGSSn6NPB-92NBtw--6se7XNYaPzTiUd1P-XGFbqR3pQoul423aT4P2jIKdfI5RBbUKx0Pc6QhqLYowQKRtZ8wmdH1CbUykZ_FMNJWo_jPJrdTTMFHh3_Lkn_N8SE_DxAPwOPeye0anFty9scXNc8BdnV6Cv |
CitedBy_id | crossref_primary_10_1016_j_placenta_2021_09_014 crossref_primary_10_1007_s13238_020_00804_9 crossref_primary_10_3389_fendo_2023_1267195 crossref_primary_10_1016_j_bbih_2023_100674 crossref_primary_10_1016_j_mam_2022_101095 crossref_primary_10_1177_1753495X241251425 crossref_primary_10_1186_s12884_022_05211_y crossref_primary_10_1016_j_aohep_2024_101490 crossref_primary_10_1016_j_isci_2022_105453 crossref_primary_10_1080_17474124_2021_2011211 crossref_primary_10_1007_s12072_023_10604_y crossref_primary_10_3389_fphys_2023_1213757 crossref_primary_10_7554_eLife_71094 crossref_primary_10_1016_j_jep_2019_112358 crossref_primary_10_1134_S1022795420100099 crossref_primary_10_1097_HJH_0000000000003577 crossref_primary_10_1016_j_bbrc_2019_10_056 crossref_primary_10_1016_S2468_1253_21_00074_1 crossref_primary_10_1111_jog_15253 crossref_primary_10_1016_j_bbr_2021_113635 crossref_primary_10_1002_uog_27591 crossref_primary_10_1016_j_intimp_2020_107328 crossref_primary_10_1093_infdis_jiac222 crossref_primary_10_3390_ijms24119511 crossref_primary_10_1055_s_0040_1722264 crossref_primary_10_1016_j_ajogmf_2023_100952 crossref_primary_10_3390_ijms222313149 |
Cites_doi | 10.1002/hep.24492 10.1093/jmcb/mjw025 10.1016/j.placenta.2011.09.006 10.1210/endo.142.5.8115 10.1042/cs1030191 10.1124/mol.64.3.610 10.1186/1477-7819-12-164 10.1111/nan.12342 10.1111/1471-0528.12174 10.1016/0002-9378(72)90909-X 10.1002/hep.26617 10.1111/bcp.12480 10.1371/journal.pone.0083281 10.3109/15513815.2014.899413 10.1136/bmj.k104 10.1016/S0021-9258(18)53136-7 10.1002/bdd.2150 10.4103/0019-5154.113971 10.1113/jphysiol.2010.198549 10.1038/nutd.2016.10 10.1172/JCI68927 10.1016/j.bbrc.2018.10.074 10.1016/0028-2243(91)90222-7 10.1046/j.1469-0705.1991.01030192.x 10.1053/plac.2002.0879 10.1186/2049-3002-2-1 10.1371/journal.pone.0083828 10.1042/CS20110184 10.1042/CS20000164 10.1136/heartjnl-2013-304546 10.1186/s12876-015-0324-0 |
ContentType | Journal Article |
Copyright | FASEB The Author(s) 2019 FASEB |
Copyright_xml | – notice: FASEB – notice: The Author(s) 2019 FASEB |
DBID | 24P WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1096/fj.201900015RR |
DatabaseName | Wiley-Blackwell Open Access Collection Wiley Online Library Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1530-6860 |
EndPage | 8220 |
ExternalDocumentID | 10_1096_fj_201900015RR 30922127 FSB2FJ201900015RR |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Biological Sciences Research Council funderid: BB/L020823/1; BB/R002762/1 |
GroupedDBID | --- -DZ -~X .55 0R~ 0VX 123 18M 1OB 1OC 24P 29H 2WC 33P 34G 39C 3O- 4.4 53G 5GY 5RE 85S AAHHS AANLZ ABCUV ABDNZ ABEFU ABJNI ABOCM ACCFJ ACCZN ACGFS ACIWK ACNCT ACPOU ACPRK ACXQS ACYGS ADKYN ADZMN AEEZP AEIGN AENEX AEQDE AEUYR AFFNX AFFPM AFRAH AGCDD AHBTC AI. AITYG AIURR AIWBW AIZAD AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMYDB BFHJK BIYOS C1A CS3 DCZOG DU5 D~5 E3Z EBS EJD F20 F5P F9R FRP H13 HGLYW HZ~ H~9 J5H L7B LATKE LEEKS MEWTI MVM NEJ O9- OHT OVD Q-A RHF RHI RJQFR ROL SAMSI SJN SUPJJ TEORI TFA TR2 TWZ VH1 W8F WH7 WHG WIN WOQ WXSBR X7M XJT XOL XSW Y6R YBU YCJ YHG YKV YNH YSK Z0Y ZCA ZE2 ZGI ZXP ~KM CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c444R-e10d7b18537eb0ff3dd37ab2907e23db2c0acb5b5cdf2ef116ba7622f41b77273 |
IEDL.DBID | 33P |
ISSN | 0892-6638 |
IngestDate | Tue Sep 17 21:15:22 EDT 2024 Fri Oct 25 02:29:37 EDT 2024 Fri Nov 22 00:50:26 EST 2024 Sat Sep 28 08:46:40 EDT 2024 Sat Aug 24 01:07:42 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | membrane transport OATP4A1 vasoconstriction |
Language | English |
License | Attribution This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c444R-e10d7b18537eb0ff3dd37ab2907e23db2c0acb5b5cdf2ef116ba7622f41b77273 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1096%2Ffj.201900015RR |
PMID | 30922127 |
PQID | 2200775743 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6593889 proquest_miscellaneous_2200775743 crossref_primary_10_1096_fj_201900015RR pubmed_primary_30922127 wiley_primary_10_1096_fj_201900015RR_FSB2FJ201900015RR |
PublicationCentury | 2000 |
PublicationDate | July 2019 |
PublicationDateYYYYMMDD | 2019-07-01 |
PublicationDate_xml | – month: 07 year: 2019 text: July 2019 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bethesda, MD, USA |
PublicationTitle | The FASEB journal |
PublicationTitleAlternate | FASEB J |
PublicationYear | 2019 |
Publisher | Federation of American Societies for Experimental Biology |
Publisher_xml | – name: Federation of American Societies for Experimental Biology |
References | 2015; 79 2001; 100 2015; 15 1991; 1 2001; 142 2018; 360 2017; 43 2017; 23 2013; 123 2011; 32 2011; 54 2018; 506 2013; 120 2014; 41 1993; 268 2013; 8 1972; 114 2011; 589 2016; 6 2018; 39 2013; 58 2014; 2 2013; 99 1991; 42 2002; 103 2003; 24 2014; 59 2014; 9 2014; 12 2003; 64 2016; 8 2014; 33 2011; 121 e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 Ghosh S. (e_1_2_8_2_1) 2013; 58 e_1_2_8_3_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_14_1 Wang H. (e_1_2_8_11_1) 2014; 41 e_1_2_8_15_1 e_1_2_8_16_1 Gu H. (e_1_2_8_35_1) 2017; 23 Shneider B. L. (e_1_2_8_21_1) 1993; 268 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 Dolinsky B. M. (e_1_2_8_7_1) 2014; 59 |
References_xml | – volume: 59 start-page: 1482 year: 2014 end-page: 1491 article-title: Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study publication-title: Hepatology – volume: 142 start-page: 2005 year: 2001 end-page: 2012 article-title: Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner publication-title: Endocrinobgy – volume: 123 start-page: 3172 year: 2013 end-page: 3181 article-title: Maternal cholestasis during pregnancy programs metabolic disease in offspring publication-title: J. Clin. Invest. – volume: 103 start-page: 191 year: 2002 end-page: 200 article-title: Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics publication-title: Clin. Sci. (Lond.) – volume: 15 start-page: 92 year: 2015 article-title: Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid publication-title: BMC Gastroenterol. – volume: 100 start-page: 363 year: 2001 end-page: 369 article-title: The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis publication-title: Clin. Sci. (Lond.) – volume: 32 start-page: 1026 year: 2011 end-page: 1032 article-title: A placental phenotype for intrahepatic cholestasis of pregnancy publication-title: Placenta – volume: 8 year: 2013 article-title: Comparative proteomics analysis of placenta from pregnant women with intrahepatic cholestasis of pregnancy publication-title: PLoS One – volume: 268 start-page: 6985 year: 1993 end-page: 6988 article-title: Characterization of endogenous carrier-mediated taurocholate efflux from Xenopus laevis oocytes publication-title: J. Biol. Chem. – volume: 43 start-page: 492 year: 2017 end-page: 504 article-title: Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy publication-title: Neuropathol. Appl. Neurobiol. – volume: 64 start-page: 610 year: 2003 end-page: 618 article-title: Breast cancer resistance protein exports sulfated estrogens but not free estrogens publication-title: Mol. Pharmacol. – volume: 121 start-page: 523 year: 2011 end-page: 544 article-title: Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications publication-title: Clin. Sci. (Lond.) – volume: 120 start-page: 717 year: 2013 end-page: 723 article-title: Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study publication-title: BJOG. – volume: 39 start-page: 335 year: 2018 end-page: 343 article-title: Transport mechanism of ursodeoxycholic acid in human placental BeWo cells publication-title: Biopharm. DrugDispos. – volume: 79 start-page: 316 year: 2015 end-page: 329 article-title: Effect of ursodeoxycholic acid treatment on the altered progesterone and bile acid homeostasis in the mother-placenta-foetus trio during cholestasis of pregnancy publication-title: Br. J. Clin. Pharmacol. – volume: 41 start-page: 692 year: 2014 end-page: 694 article-title: Expression and significance of organic anion transporting polypeptides 4A1 (OATP4A1), OATP2B1 in placenta of intrahepatic cholestasis of pregnancy publication-title: J. Int. Obstet. Gynecol. – volume: 24 start-page: 39 year: 2003 end-page: 44 article-title: Semi quantitative expression analysis of MDR3, FIC1, BSEP, OATP-A, OATP-C, OATP-D, OATP-E and NTCP gene transcripts in 1st and 3rd trimester human placenta publication-title: Placenta – volume: 2 start-page: 1 year: 2014 end-page: 9 article-title: TIGAR, TIGAR, burning bright publication-title: Cancer Metab. – volume: 99 start-page: 1629 year: 2013 end-page: 1630 article-title: Bile acids induce arrhythmias: old metabolite, new tricks publication-title: Heart – volume: 360 year: 2018 article-title: Does ursodeoxycholic acid improve perinatal outcomes in women with intrahepatic cholestasis of pregnancy? publication-title: BMJ – volume: 8 start-page: 530 year: 2016 end-page: 541 article-title: Bile acids evoke placental inflammation by activating Gpbarl/NF-κB pathway in intrahepatic cholestasis of pregnancy publication-title: J. Mol. Cell Biol. – volume: 42 start-page: 211 year: 1991 end-page: 215 article-title: Vasoconstrictive effect of bile acids on isolated human placental chorionic veins publication-title: Eur. J. Obstet. Gynecol. Reprod. Biol. – volume: 6 year: 2016 article-title: Hypothalamus proteomics from mouse models with obesity and anorexia reveals therapeutic targets of appetite regulation publication-title: Nutr. Diabetes – volume: 58 start-page: 327 year: 2013 article-title: Intra-hepatic cholestasis of pregnancy: a comprehensive review publication-title: Indian J. Dermatol. – volume: 33 start-page: 210 year: 2014 end-page: 215 article-title: A case-control review of placentas from patients with intrahepatic cholestasis of pregnancy publication-title: Fetal Pediatr. Pathol. – volume: 59 start-page: 367 year: 2014 end-page: 370 article-title: Effect of taurocholic acid on fetoplacental arterial pressures in a dual perfusion placental cotyledon model: a novel approach to intrahepatic cholestasis of pregnancy publication-title: J. Reprod. Med. – volume: 9 year: 2014 article-title: The reversed feto-maternal bile acid gradient in intrahepatic cholestasis of pregnancy is corrected by ursodeoxycholic acid publication-title: PLoS One – volume: 12 start-page: 164 year: 2014 article-title: Secondary bile acids: an underrecognized cause of colon cancer publication-title: World J. Surg. Oncol. – volume: 54 start-page: 1282 year: 2011 end-page: 1292 article-title: A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart publication-title: Hepatobgy – volume: 1 start-page: 192 year: 1991 end-page: 196 article-title: The clinical significance of absent or reverse end-diastolic flow in the fetal aorta and umbilical artery publication-title: Ultrasound Obstet. Gynecol. – volume: 589 start-page: 987 year: 2011 end-page: 997 article-title: Facilitated transporters mediate net efflux of amino acids to the fetus across the basal membrane of the placental syncytiotrophoblast publication-title: J. Physiol. – volume: 23 start-page: 70 year: 2017 end-page: 73 article-title: Correlation between the umbilical artery flow ultrasound parameters of intrauterine fetal distress and fetal ischemic hypoxic damage publication-title: Hainan Yixueyuan Xuebao – volume: 114 start-page: 822 year: 1972 end-page: 828 article-title: Transfer across the perfused human placenta of antipyrine, sodium and leucine publication-title: Am. J. Obstet. Gynecol. – volume: 506 start-page: 237 year: 2018 end-page: 242 article-title: Estrone sulphate uptake by the microvillous membrane of placental syncytiotrophoblast is coupled to glutamate efflux publication-title: Biochem. Biophys. Res. Commun. – ident: e_1_2_8_30_1 doi: 10.1002/hep.24492 – ident: e_1_2_8_16_1 doi: 10.1093/jmcb/mjw025 – ident: e_1_2_8_19_1 doi: 10.1016/j.placenta.2011.09.006 – volume: 23 start-page: 70 year: 2017 ident: e_1_2_8_35_1 article-title: Correlation between the umbilical artery flow ultrasound parameters of intrauterine fetal distress and fetal ischemic hypoxic damage publication-title: Hainan Yixueyuan Xuebao contributor: fullname: Gu H. – ident: e_1_2_8_12_1 doi: 10.1210/endo.142.5.8115 – ident: e_1_2_8_26_1 doi: 10.1042/cs1030191 – ident: e_1_2_8_13_1 doi: 10.1124/mol.64.3.610 – volume: 41 start-page: 692 year: 2014 ident: e_1_2_8_11_1 article-title: Expression and significance of organic anion transporting polypeptides 4A1 (OATP4A1), OATP2B1 in placenta of intrahepatic cholestasis of pregnancy publication-title: J. Int. Obstet. Gynecol. contributor: fullname: Wang H. – ident: e_1_2_8_5_1 doi: 10.1186/1477-7819-12-164 – ident: e_1_2_8_25_1 doi: 10.1111/nan.12342 – ident: e_1_2_8_4_1 doi: 10.1111/1471-0528.12174 – ident: e_1_2_8_22_1 doi: 10.1016/0002-9378(72)90909-X – ident: e_1_2_8_32_1 doi: 10.1002/hep.26617 – ident: e_1_2_8_10_1 doi: 10.1111/bcp.12480 – ident: e_1_2_8_31_1 doi: 10.1371/journal.pone.0083281 – ident: e_1_2_8_17_1 doi: 10.3109/15513815.2014.899413 – ident: e_1_2_8_20_1 doi: 10.1136/bmj.k104 – volume: 268 start-page: 6985 year: 1993 ident: e_1_2_8_21_1 article-title: Characterization of endogenous carrier-mediated taurocholate efflux from Xenopus laevis oocytes publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)53136-7 contributor: fullname: Shneider B. L. – ident: e_1_2_8_29_1 doi: 10.1002/bdd.2150 – volume: 58 start-page: 327 year: 2013 ident: e_1_2_8_2_1 article-title: Intra-hepatic cholestasis of pregnancy: a comprehensive review publication-title: Indian J. Dermatol. doi: 10.4103/0019-5154.113971 contributor: fullname: Ghosh S. – ident: e_1_2_8_23_1 doi: 10.1113/jphysiol.2010.198549 – ident: e_1_2_8_24_1 doi: 10.1038/nutd.2016.10 – ident: e_1_2_8_3_1 doi: 10.1172/JCI68927 – ident: e_1_2_8_28_1 doi: 10.1016/j.bbrc.2018.10.074 – ident: e_1_2_8_8_1 doi: 10.1016/0028-2243(91)90222-7 – ident: e_1_2_8_34_1 doi: 10.1046/j.1469-0705.1991.01030192.x – ident: e_1_2_8_14_1 doi: 10.1053/plac.2002.0879 – ident: e_1_2_8_33_1 doi: 10.1186/2049-3002-2-1 – ident: e_1_2_8_6_1 doi: 10.1371/journal.pone.0083828 – ident: e_1_2_8_15_1 doi: 10.1042/CS20110184 – volume: 59 start-page: 367 year: 2014 ident: e_1_2_8_7_1 article-title: Effect of taurocholic acid on fetoplacental arterial pressures in a dual perfusion placental cotyledon model: a novel approach to intrahepatic cholestasis of pregnancy publication-title: J. Reprod. Med. contributor: fullname: Dolinsky B. M. – ident: e_1_2_8_27_1 doi: 10.1042/CS20000164 – ident: e_1_2_8_9_1 doi: 10.1136/heartjnl-2013-304546 – ident: e_1_2_8_18_1 doi: 10.1186/s12876-015-0324-0 |
SSID | ssj0001016 |
Score | 2.5017347 |
Snippet | ABSTRACT
Intrahepatic cholestasis of pregnancy (ICP) causes increased transfer of maternal bile acids to the fetus and an increased incidence of sudden fetal... Intrahepatic cholestasis of pregnancy (ICP) causes increased transfer of maternal bile acids to the fetus and an increased incidence of sudden fetal death.... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 8211 |
SubjectTerms | Animals Autophagic Cell Death - drug effects Female Humans Male membrane transport OATP4A1 Organic Anion Transporters - metabolism Oxidative Stress - drug effects Placenta - blood supply Placenta - metabolism Pregnancy Rats Rats, Wistar Taurocholic Acid - metabolism Ursodeoxycholic Acid - pharmacology vasoconstriction Vasoconstriction - drug effects Xenopus laevis |
Title | Ursodeoxycholic acid inhibits uptake and vasoconstrictor effects of taurocholate in human placenta |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1096%2Ffj.201900015RR https://www.ncbi.nlm.nih.gov/pubmed/30922127 https://search.proquest.com/docview/2200775743 https://pubmed.ncbi.nlm.nih.gov/PMC6593889 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7oQPDF-6XeiCD4VGyTrGkfvY3hg8jmwLeSNAnrhG64VvTfm6Rb2diDoI-9pLQ9zXe-05zzHYArGcYci5j7EabSp4Ri3zhB5guRSK1ioji2tcPdPnt-ix8erUxOU8Vf60M0P9zszHB4bSc4F9OZAJKNN_XIJmYlrhi41zMgbEIFV8NBXhootqGpo5EJ9o1rjRvVxuhmefiyV1qhmqsZk4tM1rmizvb_H2IHtmY0FN3W380urKliDzbqxpTf-yAGhodLNf5y6JhniGe5RHkxzEVeTlE1Kfm7QryQ6JMb81qOafDUhO9olh-CxhqVvLL9uEzsXCozFrl2gMglgRUlP4BB5_H1vuvPujH4GaW056swkExY986UCLQmUhLGBTbRtcJECpwFPBNt0c6kxkqHYSS4QVqsaSiYZUmH0CrGhToGZOuFMW8buFARFSxImGKZxEKTjCpDWTy4nlsjndSiG2m9WB6lepQuvDEPLufGSs28sIsdvFDjappi7NT9DEHy4Kg2XnMtEiTYKtt7wJbM2pxgNbeXjxT50GlvR-2ExHHiQeTM-svtpZ3-He48Lew5-evAU9i0W3Wm8Bm0yo9KncP6VFYX7pv_AdSoAqw |
link.rule.ids | 230,315,782,786,887,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwEB7xECqXFmihoUBdCYlTRGJ74-TIa7VQQNUCUm-RHdsiIGURm1Ttv6_H2Y12xQEJcY3jKMl4Zr6xZ74B2NdxKqlKZZhQrkPOOA2dExShUpm2JmVGUqwdHtyI69_p6RnS5BxNa2Fafohuww01w9trVHDckJ4wIGHAaR8wMyvz1cDD4SIs88StRqziYL86Y4zBqQeSGQ2dc0073sbkcH7-vF96ATZf5kzOYlnvjPqf3uEz1uDjBImSo3bprMOCqTZgpe1N-e8zqDsHxbUZ_fUGsiyILEpNyuq-VGU9Js1TLR8NkZUmf6STMMJMZ1JdBE8mKSJkZEktG2zJ5cLn2ri5xHcEJD4PrKrlF7jrn92eDMJJQ4aw4JwPQxNHWij08MKoyFqmNRNSURdgG8q0okUkC9VTvUJbamwcJ0o6Y0stj5VAoLQJS9WoMl-BYMkwlT1nMUzClYgyYUShqbKs4MahlgAOpuLIn1rejbw9L09y-5DP_LEAfkyllTvVwPMOWZlRM84p9QR_DiMFsNVKr3sWizKK5PYBiDm5djcg7fb8SFXee_rtpJexNM0CSLxcX3m9vH9zTPsXM1e23zrxO3wY3F5d5pfn1z-_wSqOtInDO7BUPzdmFxbHutnzCvAfJhUG1A |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB4BVREXKK8SoK2RKvUUkdjeODnyiqBFCC1F6i2yY1uEStkVmyD493icJdoVh0r0GmeiJGPPfGPPfAPwXceppCqVYUK5DjnjNHROUIRKZdqalBlJsXb4_EZc_UlPz5Amp6_i7_gh-g03XBneXuMCH2s7JUDCeNPeY2JW5ouBh8NF-MAdFkf2fMaue1uMsanHkRkNnW9Ne9rG5HBeft4tvcGab1MmZ6Gs90X52v9_xSdYneJQctRNnHVYMPUGfOw6Uz5vgrp1QFyb0ZM3j1VJZFlpUtV3laqaCWnHjfxriKw1eZROvwgynUF18TuZJoiQkSWNbLEhlwueG-Nkie8HSHwWWN3ILbjNz36fnIfTdgxhyTkfhiaOtFDo34VRkbVMayakoi68NpRpRctIlmqgBqW21Ng4TpR0ppZaHiuBMGkblupRbXaAYMEwlQNnL0zClYgyYUSpqbKs5MZhlgB-vGqjGHesG0V3Wp4U9r6Y-WMBHLwqq3ALA087ZG1G7aSg1NP7OYQUwOdOef2zWJRRpLYPQMyptb8BSbfnR-rqzpNvJ4OMpWkWQOLV-o_XK_KbY5r_nLmy-17Bb7B8fZoXlxdXv_ZgBQe6rOF9WGoeWvMFFie6_eqn_wvtvwV6 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ursodeoxycholic+acid+inhibits+uptake+and+vasoconstrictor+effects+of+taurocholate+in+human+placenta&rft.jtitle=The+FASEB+journal&rft.au=Lofthouse%2C+Emma+M.&rft.au=Torrens%2C+Christopher&rft.au=Manousopoulou%2C+Antigoni&rft.au=Nahar%2C+Monica&rft.date=2019-07-01&rft.pub=Federation+of+American+Societies+for+Experimental+Biology&rft.issn=0892-6638&rft.eissn=1530-6860&rft.volume=33&rft.issue=7&rft.spage=8211&rft.epage=8220&rft_id=info:doi/10.1096%2Ffj.201900015RR&rft.externalDBID=10.1096%252Ffj.201900015RR&rft.externalDocID=FSB2FJ201900015RR |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0892-6638&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0892-6638&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0892-6638&client=summon |